Bel Air, MD, United States of America

Paul F Jackson

USPTO Granted Patents = 45 

Average Co-Inventor Count = 2.9

ph-index = 21

Forward Citations = 1,201(Granted Patents)


Location History:

  • Bel Air, MD (US) (1997 - 2003)
  • White House Station, NJ (US) (2002 - 2005)

Company Filing History:


Years Active: 1997-2005

Loading Chart...
45 patents (USPTO):Explore Patents

Title: Paul F Jackson: Innovator Extraordinaire

Introduction:

Meet Paul F Jackson, a renowned inventor and patent holder based in Bel Air, Maryland. With an impressive track record of 45 patents under his belt, Jackson is a pioneer in the field of pharmaceutical compositions and diagnostic methods. His groundbreaking work has contributed significantly to the development of various treatment modalities for a wide range of diseases. Let's delve deeper into his latest patents, career highlights, notable collaborations, and the lasting impact of his extraordinary contributions.

Latest Patents:

Jackson's latest patents are a testament to his innovative mindset and dedication to advancing medical science. One of his recent patents involves benzenedicarboxylic acid derivatives, which are novel compounds used in pharmaceutical compositions, diagnostic methodologies, and kits. These compounds exhibit the potential to inhibit NAALADase enzyme activity, detect diseases with altered NAALADase levels, and treat conditions such as neuropathy, pain, prostate diseases, cancers, and glaucoma.

Another noteworthy patent from Jackson revolves around PARP inhibitors, which have shown promise in treating tissue damage resulting from cell death or necrosis. These inhibitors have a wide scope of applications, including the treatment of neurodegenerative diseases, neural tissue damage from ischemia, cardiovascular disorders, immune senescence diseases, arthritis, and cancer. Moreover, they can potentially extend the lifespan and proliferative capacity of cells.

Career Highlights:

Throughout his illustrious career, Jackson has made significant contributions to the pharmaceutical industry. Notably, he has worked with esteemed companies such as Guilford Pharmaceuticals, Inc., and Zeneca Limited. Through his involvement with these organizations, Jackson had the opportunity to engage in cutting-edge research, further cementing his expertise and reputation as an innovator.

Collaborations:

Collaboration plays a vital role in scientific advancements, and Jackson has had the privilege of working with esteemed professionals in his field. One of his notable collaborators is Barbara S Slusher, whose expertise in medicinal chemistry has likely complemented Jackson's innovative research. Keith M Maclin is another significant collaborator, contributing valuable insights and expertise to their shared projects. Through collaborations, Jackson has been able to leverage collective knowledge and expertise, unlocking new avenues for innovation.

Conclusion:

Paul F Jackson, based in Bel Air, Maryland, is a pioneer in the field of pharmaceutical compositions and diagnostic methods. With an impressive array of 45 patents, Jackson has made significant contributions to the medical field, securing his place as an influential innovator. His latest patents, including benzenedicarboxylic acid derivatives and PARP inhibitors, showcase his dedication to advancing medical science and improving the lives of countless individuals. Through his collaborations and career highlights with notable companies, Jackson continues to leave a lasting impact on the field of innovations and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…